Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Michigan Cancer Research Consortium
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Kalamazoo
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Southern Nevada Cancer Research Foundation
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
Veterans Affairs Medical Center - East Orange
mi
from
East Orange, NJ
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Northern New Jersey
mi
from
Hackensack, NJ
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Northern New Jersey
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
NYU School of Medicine's Kaplan Comprehensive Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
MetroHealth's Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
MetroHealth's Cancer Care Center at MetroHealth Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Columbus
mi
from
Columbus, OH
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Columbus
mi
from
Columbus, OH
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Scott and White Hospital
mi
from
Temple, TX
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Scott and White Hospital
mi
from
Temple, TX
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Marshfield Clinic Research Foundation
mi
from
Marshfield, WI
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
Medical College of Wisconsin Cancer Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Status: Enrolling
Updated:  10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Status: Enrolling
Updated: 10/13/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin
Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin
Status: Enrolling
Updated:  10/15/2015
The Ohio State University General Internal Medicine
mi
from
Columbus, OH
Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin
Comparison of Two Pharmacist-led Population Management Approaches to Increase Monitoring of Vitamin B12 and Serum Creatinine Levels for Patients on Metformin
Status: Enrolling
Updated: 10/15/2015
The Ohio State University General Internal Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Lakeview Medical Research
mi
from
Summerfield, FL
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Lakeview Medical Research
mi
from
Summerfield, FL
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
St. Joseph's/Candler Health System
mi
from
Savannah, GA
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
St. Joseph's/Candler Health System
mi
from
Savannah, GA
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Johns Hopkins University Geriatrics Center
mi
from
Baltimore, MD
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Johns Hopkins University Geriatrics Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Case Western Reserve University Medical Center
mi
from
Cleveland, OH
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Case Western Reserve University Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Clinical Research Solutions
mi
from
Columbia, TN
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Clinical Research Solutions
mi
from
Columbia, TN
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Clinical Research Solutions
mi
from
Franklin, TN
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Clinical Research Solutions
mi
from
Franklin, TN
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Clinical Research Solutions
mi
from
Smyrna, TN
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Clinical Research Solutions
mi
from
Smyrna, TN
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
University of Utah School of Medicine
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated:  10/26/2015
Institute for Advanced Studies in Aging (IASIA)
mi
from
Falls Church, VA
Trial To Evaluate the Efficacy of Oral Salsalate in the Treatment of Older Adults With Unexplained Anemia
A Randomized, Double-Blind, Placebo Controlled Pilot Trial of Oral Salsalate in the Treatment of the Subset of Unexplained Anemia in Elderly Patients With Elevated Interleukin-6
Status: Enrolling
Updated: 10/26/2015
Institute for Advanced Studies in Aging (IASIA)
mi
from
Falls Church, VA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Birmingham, AL
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Hot Springs, AR
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Bakersfield, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Mountain View, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Mountain View, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Riverside, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
San Diego, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
San Leandro, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
San Leandro, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Simi Valley, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Simi Valley, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Whittier, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Yuba City, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Yuba City, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Lakewood, CO
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Lakewood, CO
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Stamford, CT
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Stamford, CT
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Brandon, FL
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Ocala, FL
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
A Study of Subcutaneous Mircera for the Treatment of Anemia in Peritoneal Dialysis Patients.
A Randomized, Open Label Study to Compare the Effect of Monthly Injections of Mircera Versus Epoetin Alfa on Hemoglobin Levels in Peritoneal Dialysis Patients Who Self-inject or Receive In-center Injections
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials